164 related articles for article (PubMed ID: 12079507)
1. Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer.
Fukuhara H; Kuramochi M; Fukami T; Kasahara K; Furuhata M; Nobukuni T; Maruyama T; Isogai K; Sekiya T; Shuin T; Kitamura T; Reeves RH; Murakami Y
Jpn J Cancer Res; 2002 Jun; 93(6):605-9. PubMed ID: 12079507
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines.
Honda T; Tamura G; Waki T; Jin Z; Sato K; Motoyama T; Kawata S; Kimura W; Nishizuka S; Murakami Y
Jpn J Cancer Res; 2002 Aug; 93(8):857-60. PubMed ID: 12716461
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
Fukami T; Fukuhara H; Kuramochi M; Maruyama T; Isogai K; Sakamoto M; Takamoto S; Murakami Y
Int J Cancer; 2003 Oct; 107(1):53-9. PubMed ID: 12925956
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.
Jansen M; Fukushima N; Rosty C; Walter K; Altink R; Heek TV; Hruban R; Offerhaus JG; Goggins M
Cancer Biol Ther; 2002; 1(3):293-6. PubMed ID: 12432281
[TBL] [Abstract][Full Text] [Related]
5. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
7. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.
Kuramochi M; Fukuhara H; Nobukuni T; Kanbe T; Maruyama T; Ghosh HP; Pletcher M; Isomura M; Onizuka M; Kitamura T; Sekiya T; Reeves RH; Murakami Y
Nat Genet; 2001 Apr; 27(4):427-30. PubMed ID: 11279526
[TBL] [Abstract][Full Text] [Related]
8. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation.
Allinen M; Peri L; Kujala S; Lahti-Domenici J; Outila K; Karppinen SM; Launonen V; Winqvist R
Genes Chromosomes Cancer; 2002 Aug; 34(4):384-9. PubMed ID: 12112527
[TBL] [Abstract][Full Text] [Related]
9. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y
Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787
[TBL] [Abstract][Full Text] [Related]
11. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
[TBL] [Abstract][Full Text] [Related]
12. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.
Mao X; Seidlitz E; Ghosh K; Murakami Y; Ghosh HP
Cancer Res; 2003 Nov; 63(22):7979-85. PubMed ID: 14633730
[TBL] [Abstract][Full Text] [Related]
13. TSLC1 gene silencing in cutaneous melanoma.
You Y; Ma L; You M; Li X; Wang S; Li H; Wu D; Yang H; Li ZY
Melanoma Res; 2010 Jun; 20(3):179-83. PubMed ID: 20375924
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between the TSLC1 silencing and DNA methylation in human lung cancer cells].
Ming S; Gao J; Sun T
Zhongguo Fei Ai Za Zhi; 2010 May; 13(5):464-9. PubMed ID: 20677643
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.
Heller G; Geradts J; Ziegler B; Newsham I; Filipits M; Markis-Ritzinger EM; Kandioler D; Berger W; Stiglbauer W; Depisch D; Pirker R; Zielinski CC; Zöchbauer-Müller S
Breast Cancer Res Treat; 2007 Jul; 103(3):283-91. PubMed ID: 17260099
[TBL] [Abstract][Full Text] [Related]
16. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
17. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
Chen K; Wang G; Peng L; Liu S; Fu X; Zhou Y; Yu H; Li A; Li J; Zhang S; Bai Y; Zhang Y
Int J Cancer; 2011 Jan; 128(2):266-73. PubMed ID: 20340131
[TBL] [Abstract][Full Text] [Related]
18. Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis.
Murakami Y
Cancer Sci; 2005 Sep; 96(9):543-52. PubMed ID: 16128739
[TBL] [Abstract][Full Text] [Related]
19. The minimal Tumor Suppressor in Lung Cancer-1 promoter is restrained by an inhibitory region.
Hori RT
Mol Biol Rep; 2010 Apr; 37(4):1979-85. PubMed ID: 19653122
[TBL] [Abstract][Full Text] [Related]
20. Isolation of the TSLL1 and TSLL2 genes, members of the tumor suppressor TSLC1 gene family encoding transmembrane proteins.
Fukuhara H; Kuramochi M; Nobukuni T; Fukami T; Saino M; Maruyama T; Nomura S; Sekiya T; Murakami Y
Oncogene; 2001 Aug; 20(38):5401-7. PubMed ID: 11536053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]